Momentum Biotechnologies
Wendy Picariello has a diverse and extensive background in the field of bioanalytical chemistry and research. With experience spanning over two decades, Wendy has held various roles in different companies, from research technician to VP of Operations. Wendy's expertise includes method development, sample analysis, project management, and assay performance. Wendy has a strong educational background with a B.S. in Biology/Chemistry from Evangel University and additional education from Northeastern University. Wendy is currently serving as VP of Operations at Momentum Biotechnologies, where Wendy continues to showcase their skills and knowledge in the field.
Momentum Biotechnologies
Momentum Biotechnologies is a drug discovery partner that delivers innovative mass spec solutions to overcome research challenges for biopharma clients globally. Our core team of scientists and engineers started working together developing the RapidFire high-throughput MS platform and have been serving clients with MS-based services since 2004 including PureHoney Technologies (2015-23). Momentum Biotechnologies’ goal is to accelerate our partners’ drug discovery & development programs through superior mass spec based CRO services. We help clients identify and characterize leads for degraders, molecular glues, protein-protein interaction (PPI) disrupters, RNA binders and other target classes. We use innovative techniques including affinity selection MS (ASMS), intact mass MS, chemoproteomics and small & biomolecule analyses. We pride ourselves on rapid turnaround of the highest quality data, accelerating the momentum of our clients’ research projects. We have a large Mass Spec lab with 30+ instruments and a fully functional BL2 lab in Billerica, Massachusetts. For more information, please visit www.momentum.bio.